1 | in high energy physics | | | | | | | 2 | 0.19% |
2 | atlas upgrades for the | | | | | | | 2 | 0.19% |
3 | ifae researcher gerard ariño | | | | | | | 2 | 0.19% |
4 | test facility etpathfinder enters | | | | | | | 2 | 0.19% |
5 | facility etpathfinder enters new | | | | | | | 2 | 0.19% |
6 | how to get here | | | | | | | 2 | 0.19% |
7 | particles to the cosmos | | | | | | | 2 | 0.19% |
8 | from particles to the | | | | | | | 2 | 0.19% |
9 | as chair of the | | | | | | | 2 | 0.19% |
10 | linkedin linkedin icon indico | | | | | | | 2 | 0.19% |
11 | logo la caixa logo | | | | | | | 2 | 0.19% |
12 | information mastercosmosbcn poster education | | | | | | | 2 | 0.19% |
13 | the atlas upgrades for | | | | | | | 2 | 0.19% |
14 | program in high energy | | | | | | | 2 | 0.19% |
15 | postgraduate program in high | | | | | | | 2 | 0.19% |
16 | member of bist logo | | | | | | | 2 | 0.19% |
17 | been received at ifae | | | | | | | 1 | 0.09% |
18 | testing april 24 2024 | | | | | | | 1 | 0.09% |
19 | april 24 2024 the | | | | | | | 1 | 0.09% |
20 | 24 2024 the first | | | | | | | 1 | 0.09% |
21 | 2024 the first samples | | | | | | | 1 | 0.09% |
22 | the first samples of | | | | | | | 1 | 0.09% |
23 | minicactusv2 sensor have been | | | | | | | 1 | 0.09% |
24 | sensor have been received | | | | | | | 1 | 0.09% |
25 | have been received at | | | | | | | 1 | 0.09% |
26 | instrumentation test facility etpathfinder | | | | | | | 1 | 0.09% |
27 | received at ifae read | | | | | | | 1 | 0.09% |
28 | at ifae read more | | | | | | | 1 | 0.09% |
29 | ready for testing april | | | | | | | 1 | 0.09% |
30 | barcelona 2024 as the | | | | | | | 1 | 0.09% |
31 | etpathfinder enters new phase | | | | | | | 1 | 0.09% |
32 | enters new phase march | | | | | | | 1 | 0.09% |
33 | new phase march 12 | | | | | | | 1 | 0.09% |
34 | congress barcelona 2024 as | | | | | | | 1 | 0.09% |
35 | 2024 the ifae contributions | | | | | | | 1 | 0.09% |
36 | the ifae contributions to | | | | | | | 1 | 0.09% |
37 | for testing april 24 | | | | | | | 1 | 0.09% |
38 | is ready for testing | | | | | | | 1 | 0.09% |
39 | contributions to the etpathfinder | | | | | | | 1 | 0.09% |
40 | for targeted alpha therapy | | | | | | | 1 | 0.09% |